Cambridge Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $239K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $222K | Hold |
|
|||||
|
2024
Q3 | $236K | Hold |
|
|||||
|
2024
Q2 | $248K | Hold |
|
|||||
|
2024
Q1 | $325K | Hold |
|
|||||
|
2023
Q4 | $284K | Hold |
|
|||||
|
2023
Q3 | $235K | Hold |
|
|||||
|
2023
Q2 | $252K | Hold |
|
|||||
|
2023
Q1 | $242K | Hold |
|
|||||
|
2022
Q4 | $261K | Hold |
|
|||||
|
2022
Q3 | $236K | Hold |
|
|||||
|
2022
Q2 | $257K | Hold |
|
|||||
|
2022
Q1 | $341K | Hold |
|
|||||
|
2021
Q4 | $452K | Sell |
|
|||||
|
2021
Q3 | $536K | Sell |
|
|||||
|
2021
Q2 | $555K | Hold |
|
|||||
|
2021
Q1 | $435K | Hold |
|
|||||
|
2020
Q4 | $375K | Sell |
|
|||||
|
2020
Q3 | $408K | Hold |
|
|||||
|
2020
Q2 | $314K | Hold |
|
|||||
|
2020
Q1 | $227K | Sell |
|
|||||
|
2019
Q4 | $306K | Hold |
|
|||||
|
2019
Q3 | $265K | Hold |
|
|||||
|
2019
Q2 | $284K | Hold |
|
|||||
|
2019
Q1 | $291K | Hold |
|
|||||
|
2018
Q4 | $226K | Hold |
|
|||||
|
2018
Q3 | $269K | Hold |
|
|||||
|
2018
Q2 | $225K | Hold |
|
|||||
|
2018
Q1 | $213K | Hold |
|
|||||
|
2017
Q4 | $219K | Hold |
|
|||||
|
2017
Q3 | $216K | Hold |
|
|||||
|
2017
Q2 | $202K | Buy |
|